Guest guest Posted May 21, 2006 Report Posted May 21, 2006 Under the heading " Believe it or Not " [abmd] Children 4-6 years old with bipolar - opinion piece plus info from ClinicalTrials.gov Outrage! Preschoolers used as guinea pigs in psychotropic drug tests Posted Thursday, May 18, 2006 by Mike Print this article Permalink: http://www.NewsTarget.com/019389.html Key concepts: psychiatry, preschoolers and psychiatrists. -------------------------------------------------------------------------- -------------------------------------------------------------------------- As ClinicalTrials.gov reveals, in 2005, Massachusetts General Hospital conducted an 8-week trial study that recruited children as young as four years old to be drugged and monitored, including having their blood drawn, to see if their tiny four-year-old bodies would tolerate a powerful psychotropic drug (Seroquel). Here's more from ClinicalTrials.gov: This is an 8-week open-label study aimed at assessing the effectiveness and tolerability of Quetiapine, in the treatment of preschool children aged 4 to 6 years with bipolar and bipolar spectrum disorder. This is an exploratory, pilot study, seeking to determine whether Quetiapine is efficacious and well tolerated in the treatment of preschoolers with pediatric bipolar and bipolar spectrum disorder in this age group. Ages Eligible for Study:4 Years - 6 Years, Genders Eligible for Study: Both Subject must be able to participate in mandatory blood draws. Massachusetts General Hospital, Cambridge, Massachusetts, 02138, United States; Recruiting ph Biederman, MD, Principal Investigator Chemical child abuse In my view, this exploitation of young children for drug testing amounts to nothing less than chemical child abuse. What possible medical justification could these doctors, hospital staff and drug pushers have for prescribing mind-altering drugs to four-year-olds? Even the " disease " being treated here is entirely fictional. So-called " bi-polar disorder " was wholly invented by psychiatrists with strong financial ties to drug companies. The purpose of this disease is not to help children, but to sell drugs to anyone and everyone, including toddlers. I often wonder when the rest of the country will wake up and notice that the mass-drugging of our nation's children has gone too far. Why isn't the mainstream media giving this front-page coverage? Why aren't lawmakers demanding an end to the chemical abuse of our children? Why isn't the FDA halting these trials on toddlers out of plain decency? ou already know the answer: Because they're all making money from this chemical assault on our nation's children. The doctors, hospitals, drug companies, psychiatrists and mainstream media all profit handsomely from the sales of mind-altering drugs to children. Ethics will never get in the way of old-fashioned greed, even when we're talking about the health and lives of four-year-olds. Modern psychiatry, with all its false authority, drugging of children and rampant disease mongering, is an affront to all people who believe in honest medical science and basic human decency. Armed with the DSM-IV, on-the-take psychiatrists invent diseases out of thin air (like " bi-polar disorder " ), then vote official treatment protocols into the reference books. Yet a recent review of such decision panels reveals that one hundred percent of the psychiatrists and doctors involved in such decisions have financial ties to the drug companies that coincidentally happen to manufacture the recommended drugs. This is a life-threatening scandal of such proportion that it deserves a Dept. of Justice investigation, complete with criminal charges being brought against many of these so-called " doctors. " To characterize this as a crime against humanity is not an exaggeration. Blatant quackery Let's face it: Modern psychiatry and its incessant disease mongering amounts to quackery at its worst. This group both invents the diseases, then hawks the snake oil that " treats " those diseases. And underneath it all, there's absolutely no physiological evidence of any such diseases at all. They can be diagnosed in children on a whim, based on a mere sixty seconds of casual observation combined with the biased opinion of a drug-pushing psychiatrist being bribed by Big Pharma. Related article Mass drugging of schoolchildren remains dark secret of public education, psychiatry This is not medicine, folks. And it's certainly not science. It's just plain medical fraud. Yet the whole of conventional medicine goes along with it, pretending that nothing is amiss. Doctors, hospitals, FDA bureaucrats, teachers and even many parents just pretend that all these mysterious brain chemistry diseases have spontaneously appeared in the world over the last ten years, suddenly afflicting tens of millions of children. And thank goodness the drug companies just happened to have invented all these treatment drugs at the exact same moment in history when these psychiatric diseases became so widespread! Imagine the odds... Where are the skeptics on this issue? Where are the quack busters on the drugging of our children? The silence is deafening. They have nothing to say about the lack of science behind psychiatric disease mongering. They aren't skeptical at all. Clear thinking, it seems, isn't allowed when the conclusions might question the institutions of modern medicine. And thus, the skeptics reveal themselves as little more than purveyors of medical dogma; protectors of a drug-the-children medical cult that demands unquestioning obedience to its profit-minded beliefs. Good science has long since left psychiatry. And if you want to know the true, horrifying history of the mental health industry, visit the Citizen's Commission on Human Rights. Prepare to be shocked. Born psychotic Psychiatry believes there is no child too young to diagnose as having psychiatric disorders. It won't be long before psychiatrists will be hanging out in delivery rooms, declaring children to be mentally diseased at birth (because they keep crying, obviously) and immediately injected with powerful mind-altering drugs. To psychiatry, human life has no value other than the possibility of creating a new paying customer, and every new birth is seen as another opportunity for dispensing profitable drugs. Related article Skeptical about the skeptics: The Health Ranger answers the skeptics on natural medicine There's no end to the evil that psychiatry might do in the years ahead. As long as society continues to give psychiatrists carte blanche to invent fictitious diseases, there is no human behavior, emotion or condition that's safe from being labeled a pathology. So-called " adult ADHD screening tests " label a whopping 80 percent of participants with the disease. Behavioral disorders screenings for children demonstrate similar numbers. And the things that can get you labeled as " diseased " are all too mundane: Feeling overwhelmed, feeling distracted by modern life, handling too many projects as once, being afraid of public speaking, feeling shy in social situations... gee, is there anyone who doesn't experience these sooner or later? But it wasn't enough to attempt to drug up all the adults, you see. Modern psychiatry had to expand its markets, and that meant reaching younger and younger " customers. " A couple of decades ago, they started drugging teens with antidepressant drugs. Then they attacked younger schoolchildren with Ritalin. Now they're targeting preschoolers, and the trend is clear: Children will soon be " born psychotic " if psychiatry has anything to do with it. Years ago, the giant soda companies handed out baby bottles emblazed with the logos of their flagship soft drink products. The idea was to get mothers to feed their infants soda instead of infant formula, thereby altering the taste of the infant for life, creating a lifelong consumer of soft drinks. When I first uncovered this disturbing report, I thought it was perhaps the most evil thing a corporation could do to the health of infants. But now, psychiatry takes the prize. Using four-year-olds as guinea pigs to test psychotropic drugs is more than merely unethical; it's predatory. It's Nazi-esque in its use of human beings for medical experiments, and yet it remains strangely acceptable across society. Child Protective Services does nothing. Hospitals gladly run the trials (they get paid, of course). Psychiatrists and doctors happily drug these children, observe them, then draw their blood, all in the name of corporate profits. And thus, they all join the long and sordid history of human medical experimentation that demonstrates ethics, or human lives, or plain decency will never get in the way of the forward march of medicine. Related article Human medical experimentation in the United States: The shocking true history of modern medicine and psychiatry (1833-1965) The complicity of conventional medicine is astounding. The American Medical Association, to my knowledge, says nothing skeptical about disease mongering by psychiatry. Few doctors see any problem at all, and fewer still have the courage to speak out. The FDA, which is supposed to protect people, gladly approves one psychotropic drug after another, even for use on toddlers. Lawmakers take campaign finance contributions from drug companies and look the other way, and the mainstream media continues publicizing fictitious diseases, lending them false credibility and creating customer demand for dangerous drugs. Only a handful of doctors, authors, organizations and celebrities dare tell the truth on this issue, and they are singled out for incessant ridicule. Take Tom Cruise, for example. Although he speaks the truth about the drugging of children, he is endlessly dragged through the mud of public opinion simply because he expresses authentic passion for ending this chemical child abuse. Cruise should be applauded for his efforts, not ridiculed. Let's hospitalize the psychiatrists When it comes to mental health, there is one group of people in this country that truly needs to be drugged: The psychiatrists. Because to practice psychiatry today, and to support the mass drugging of toddlers and schoolchildren, is to demonstrate a deep-rooted madness that may justify chemical restraint. To drug toddlers, or to use them for medical experiments, should be rightly regarded as a crime. And there's no question whatsoever that the children of our nation would be safer, healthier and happier if the practice of modern psychiatry simply disappeared. Besides, the real cause of depression, mood swings, emotional disorders or other so-called " diseases " mostly comes down to diet and lifestyle. Remove the food additives and refined sugars from a child's diet, and he returns to normal in about two weeks. Feed children healthy oils, live foods, whole grains and superfoods, and you automatically create energetic, curious, fast-learning children who need no drugs. Give children some sunshine, play time and some time with nature, and you get balanced, healthy children. It's no secret, it's just common sense. Related article High carbohydrate diets and lack of exercise to blame for obesity epidemic But psychiatry has no common sense, and no one in the industry dares mention that most so-called mental disorders are really just caused by nutritional imbalances. Because to admit to the truth about the mental health of children would be to render their careers irrelevant. And no psychiatrist is going to commit career suicide by admitting that bi-polar disorder was just made up, or that toddlers need good food, not expensive drugs. Just like conventional doctors, psychiatrists have to protect their egos and revenue streams, and that means convincing parents that little ny has a brain chemistry imbalance and he'll have to take psychotropic drugs for life. The parents, as gullible as ever, naively go along with the scam, usually after being frightened into compliance by a psychiatrist who warns them what might happy to little ny of they don't drug him. " He might commit suicide, " they're sternly warned. Will the scams of modern medicine never cease? Is there no child too young to be targeted for medical experiments? Will the sinister desire for Big Pharma profits ever be balanced against basic human decency? Probably not. The world has, indeed, gone half mad. And psychiatry is standing by, ready to drug everyone, regardless of their age or mental health status. Link back to this article: http://www.NewsTarget.com/019389.html ************************** http://www.clinicaltrials.gov/ct/show/NCT00181883?order=1 Home Search Listings Resources Help What's New About Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder This study is currently recruiting patients. Verified by Massachusetts General Hospital March 2006 Sponsored by: Massachusetts General Hospital Information provided by: Massachusetts General Hospital ClinicalTrials.gov Identifier: NCT00181883 Purpose This is an 8-week open-label study aimed at assessing the effectiveness and tolerability of Quetiapine, in the treatment of preschool children aged 4 to 6 years with bipolar and bipolar spectrum disorder. This is an exploratory, pilot study, seeking to determine whether Quetiapine is efficacious and well tolerated in the treatment of preschoolers with pediatric bipolar and bipolar spectrum disorder in this age group. The study results will be used to generate hypotheses for a larger randomized controlled clinical trial with explicit hypotheses and sufficient statistical power. Condition Intervention Phase Bipolar Disorder Mania Drug: quetiapine (Seroquel) Phase IV MedlinePlus related topics: Bipolar Disorder Study Type: Interventional Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study Official Title: Open-Label Study of Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar and Bipolar Spectrum Disorder Further study details as provided by Massachusetts General Hospital: Primary Outcomes: reductions in symptoms measured by; Young-Mania Rating Scale (Y-MRS); Mania Symptom Checklist Expected Total Enrollment: 20 Study start: February 2005 S elroquil is a psychotropic agent that affects multiple neuro transmitter receptors in the brain: serotonin 5HT1A and 5HT2, dopamine D1 and D2, histamine H1 (IC50=30nM), and adrenergic receptors. This is an 8-week open-label study aimed at assessing the effectiveness and tolerability of Quetiapine, in the treatment of preschool children aged 4 to 6 years with bipolar and bipolar spectrum disorder. This is an exploratory, pilot study, seeking to determine whether Quetiapine is efficacious and well tolerated in the treatment of preschoolers with pediatric bipolar and bipolar spectrum disorder in this age group. The study results will be used to generate hypotheses for a larger randomized controlled clinical trial with explicit hypotheses and sufficient statistical power. Eligibility Ages Eligible for Study: 4 Years - 6 Years, Genders Eligible for Study: Both Criteria Inclusion Criteria: a.. Male or female subjects, 4-6 years of age. b.. Subjects must have a DSM-IV diagnosis of bipolar I, bipolar II disorder or bipolar spectrum disorder and currently displaying manic, hypomanic, or mixed symptoms (with or without psychotic features) according to the DSM-IV based on clinical assessment and confirmed by structured diagnostic interview (Kidd Schedule of Affective Disorders and Schizophrenia Epidemiological Version). Bipolar spectrum disorder (or sub-threshold bipolar disorder) is operationalized as having severe mood disturbance, which meets DSM-IV Criteria A for bipolar disorder but meet fewer elements in criteria B (only require 2 items for elation category and 3 for irritability). c.. Subjects and their legal representative must have a level of understanding sufficient to communicate intelligently with the investigator and study coordinator, and to cooperate with all tests and examinations required by the protocol. d.. Subjects and their legal representative must be considered reliable. e.. Each subject and his/her authorized legal representative must understand the nature of the study. The subject's authorized legal representative must sign an informed consent document. f.. Subjects must have an initial score on the Y-MRS total score of at least 20. g.. Subject must be able to participate in mandatory blood draws. h.. Subjects with comorbid ADHD, ODD, CD, anxiety and depressive disorders will be allowed to participate in the study provided they do not meet for any of the exclusionary criteria. i.. For concomitant stimulant therapy used to treat ADHD, subjects must have been on a stable dose of the medication for 1 month prior to study enrollment. The dose of the stimulant therapy will not change throughout the duration of the study. Exclusion Criteria: a.. Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent, or grandchild. b.. Serious, unstable illness including hepatic, renal, gastroenterological, respiratory, cardiovascular (including ischemic heart disease), endocrinologic, neurologic, immunologic, or hematologic disease. c.. Uncorrected hypothyroidism or hyperthyroidism. d.. History of severe allergies or multiple adverse drug reactions. e.. Non-febrile seizures without a clear and resolved etiology. f.. Leukopenia or history of leukopenia without a clear and resolved etiology. g.. Judged clinically to be at serious suicidal risk. h.. Any other concomitant medication with primarily central nervous system activity other than specified in Concomitant Medication portion of the protocol. i.. A non-responder or a history of intolerance to an adequate trial of Quetiapine(2 months or more at an adequate dose) as determined by the clinician. j.. Current diagnosis of schizophrenia. k.. Non English speaking subjects will not be allowed into the study for the following reasons: a) the assessment instruments are not available and have not been adequately standardized in other languages; our clinical trials facility is located in Cambridge and not in the MGH main campus without the availability of translators; c) psychiatric questionnaires and evaluations are taxing and adding the complexity of a translator has the potential to make the patient experience even more exhausting. Location and Contact Information Please refer to this study by ClinicalTrials.gov identifier NCT00181883 Meghan Dougherty, BS 617 503-1051 mdougherty2@... Massachusetts Massachusetts General Hospital, Cambridge, Massachusetts, 02138, United States; Recruiting Meghan Dougherty, BS 617-503-1051 mdougherty2@... Aleardi, BA 617 503-1405 maleardi@... ph Biederman, MD, Principal Investigator Study chairs or principal investigators ph Biederman, MD, Principal Investigator, Massachusetts General Hospital More Information Study ID Numbers: 2004-P-001509 Last Updated: March 10, 2006 Record first received: September 13, 2005 ClinicalTrials.gov Identifier: NCT00181883 Health Authority: United States: Institutional Review Board ClinicalTrials.gov processed this record on 2006-05-19 U.S. National Library of Medicine, Contact NLM Customer Service National Institutes of Health, Department of Health & Human Services Copyright, Privacy, Accessibility, Freedom of Information Act * * * * Vaccinate'em 'til they break, then sell pharms for the symptoms. Bill for all procedures. * * * * The material in this post is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www4.law.cornell.edu/uscode/17/107.html http://oregon.uoregon.edu/~csundt/documents.htm If you wish to use copyrighted material from this email for purposes that go beyond 'fair use', you must obtain permission from the copyright owner. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.